Stentys stentys.com


Public lists: Medical Devices (6162)

Stentys is developing and commercializing innovative solutions for the treatment of patients with acute myocardial infarction (AMI, or heart attack) and complex coronary artery disease. Stentys' Self-Apposing Stents are designed to adapt to vessels with ambiguous or fluctuating diameters, particularly in the post-infarction phase, in order to prevent the malapposition problems associated with conventional stents. In the APPOSITION III clinical trial, Stentys stents demonstrated a very low one ye...Show all

Stentys is developing and commercializing innovative solutions for the treatment of patients with acute myocardial infarction (AMI, or heart attack) and complex coronary artery disease. Stentys' Self-Apposing Stents are designed to adapt to vessels w...Show all

Company (IPO / Went public)

Phone: +33 1 44 53 99 42

Fax:

31 Rue Saint-Augustin

Paris, 75002
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Stentys $22.2M Oct 25, 2010
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Stentys Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Glycomed

La Jolla, California, United States
Alive / ActiveGlycomed is developing therapeutic molecules based on complex carbohydrate chemistryLogin to see details

XTENT

Menlo Park, California, United States
Alive / ActiveBased in Menlo Park, California, Xtent Inc. is a privately held developer of next generation drugeluting stent (DES) systems designed for the treatment of real-world patients, including those with complex, multi-lesion or multi-vessel coronary and peripheral vascular disease. Although the drugeluting stent (DES) market is today dominated by large companies, the interventional cardiology field has seen many technological breakthroughs that have changed market leadership.Login to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method for treating a body lumen Oct 07, 2008 Apr 14, 2015 Patent
Device and method for treating a body lumen Aug 20, 2009 Jul 17, 2012 Patent
Frangible bridge structure for a stent, and stent including such bridge structures Jan 08, 2008 Dec 06, 2011 Patent